News

rtx1 users share new insight in 11 presentations at ARVO 2024

illustrating the extensive clinical knowledge and findings that users of the rtx1 AO retinal camera have gained in a large variety of diseases that impact the retina. Please find below a brief summary – followed by information on the schedule and room numbers.

Clinical evidence: RPE cells imaged with rtx1-TFI

In a study published in Diagnostics, clinical researchers at Quinze-Vingts National Eye Hospital, INSERM and University of…

Update on AO imaging at FujiRetina

The Fuji Retina 2024 meeting was held this weekend in Tokyo. We were delighted to attend two great lectures that explained…

Near-histological retinal imaging presented at JRO

This week at the french congress JRO - Journées de Réflexions Ophtalmologiques - ophthalmologists and researchers will…

Collaborative installation of a rtx1 retinal camera in Mannheim, Germany

Imagine Eyes is deploying its retinal imaging technology in several German ophthalmology centers, thanks to the collaboration…

New rtx1 retinal camera up and running in Halle, Germany

University Medical Center Halle, Germany, is now the owner of an rtx1 Adaptive Optics Retinal Camera. The new imaging…

Photoreceptor cells quantified in RP with and without CME

Recently published in PLOS ONE, a clinical study at the Kobe Eye Center reports quantitative assessment of cone photoreceptor…

Imagine Eyes welcomes Midori Yamamoto – Kobe Eye Center

Many thanks to Midori Yamamoto, Kobe Eye Center, for visiting Imagine Eyes this week and for helping our team prepare the…

Replay available – Webinar on imaging RPE cells and pigment migration

Interview & discussion with 3 ophthalmologists, first users of rtx1 with TFI optional module, about imaging RPE cells and pigment changes.